| First Author | Wypych TP | Year | 2021 |
| Journal | Nat Immunol | Volume | 22 |
| Issue | 3 | Pages | 279-286 |
| PubMed ID | 33495652 | Mgi Jnum | J:306552 |
| Mgi Id | MGI:6706677 | Doi | 10.1038/s41590-020-00856-3 |
| Citation | Wypych TP, et al. (2021) Microbial metabolism of L-tyrosine protects against allergic airway inflammation. Nat Immunol 22(3):279-286 |
| abstractText | The constituents of the gut microbiome are determined by the local habitat, which itself is shaped by immunological pressures, such as mucosal IgA. Using a mouse model of restricted antibody repertoire, we identified a role for antibody-microbe interactions in shaping a community of bacteria with an enhanced capacity to metabolize L-tyrosine. This model led to increased concentrations of p-cresol sulfate (PCS), which protected the host against allergic airway inflammation. PCS selectively reduced CCL20 production by airway epithelial cells due to an uncoupling of epidermal growth factor receptor (EGFR) and Toll-like receptor 4 (TLR4) signaling. Together, these data reveal a gut microbe-derived metabolite pathway that acts distally on the airway epithelium to reduce allergic airway responses, such as those underpinning asthma. |
